S

Shanghai Rendu Biotechnology Co Ltd
SSE:688193

Watchlist Manager
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Watchlist
Price: 51.28 CNY -0.33% Market Closed
Market Cap: ¥2.1B

Relative Value

The Relative Value of one Shanghai Rendu Biotechnology Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 51.28 CNY, Shanghai Rendu Biotechnology Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shanghai Rendu Biotechnology Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Shanghai Rendu Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
2.1B CNY 11.8 -199.2 -59.2 -59.2
JP
Hoya Corp
TSE:7741
9.3T JPY 10.4 44.2 27.6 33
US
Medline Inc
NASDAQ:MDLN
58.4B USD 0 0 0 0
CH
Alcon AG
SIX:ALC
30.2B CHF 3.9 37.5 15.5 30.1
DK
Coloplast A/S
CSE:COLO B
118.2B DKK 4.2 32.5 15 17.9
US
Align Technology Inc
NASDAQ:ALGN
11.3B USD 2.8 29.8 13.5 17.1
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.7 28.8 12.8 20.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.6B CNY 9.4 25.8 23.3 23.3
CA
Bausch + Lomb Corp
NYSE:BLCO
5.8B USD 1.2 -18.8 19 89.9
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF 5.3 21.5 14 19
KR
HLB Inc
KOSDAQ:028300
7.1T KRW 88.1 -32.3 -74.9 -70.9
P/E Multiple
Earnings Growth PEG
CN
S
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Average P/E: 31.4
Negative Multiple: -199.2
N/A N/A
JP
Hoya Corp
TSE:7741
44.2
13%
3.4
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
37.5
25%
1.5
DK
Coloplast A/S
CSE:COLO B
32.5
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
29.8
27%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
28.8
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.8
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -18.8 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.5
32%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -32.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
S
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Average EV/EBITDA: 17.6
Negative Multiple: -59.2
N/A N/A
JP
Hoya Corp
TSE:7741
27.6
11%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
15.5
8%
1.9
DK
Coloplast A/S
CSE:COLO B
15
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
13.5
13%
1
UK
ConvaTec Group PLC
LSE:CTEC
12.8
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14
21%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -74.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
S
Shanghai Rendu Biotechnology Co Ltd
SSE:688193
Average EV/EBIT: 31.4
Negative Multiple: -59.2
N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
CH
Alcon AG
SIX:ALC
30.1
23%
1.3
DK
Coloplast A/S
CSE:COLO B
17.9
8%
2.2
US
Align Technology Inc
NASDAQ:ALGN
17.1
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
20.9
22%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
11%
2.1
CA
Bausch + Lomb Corp
NYSE:BLCO
89.9
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19
29%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -70.9 N/A N/A